These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 10823367)
41. Benefit adequacy among elderly Social Security retired-worker beneficiaries and the SSI federal benefit rate. Rupp K; Strand A; Davies P; Sears J Soc Secur Bull; 2007; 67(3):29-51. PubMed ID: 18605217 [TBL] [Abstract][Full Text] [Related]
42. Caught in between: prescription drug coverage of Medicare beneficiaries near poverty. Shea DG; Stuart BC; Briesacher B Issue Brief (Commonw Fund); 2003 Aug; (669):1-8. PubMed ID: 12926411 [No Abstract] [Full Text] [Related]
43. Will the Medicare prescription drug benefit eliminate cost barriers for older adults with diabetes mellitus? Tjia J; Schwartz JS J Am Geriatr Soc; 2006 Apr; 54(4):606-12. PubMed ID: 16686870 [TBL] [Abstract][Full Text] [Related]
44. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Emmer S; Allendorf L J Am Geriatr Soc; 2004 Jun; 52(6):1013-5. PubMed ID: 15161471 [No Abstract] [Full Text] [Related]
45. Medicare financing reform: a new Medicare premium. Davis K; Rowland D Milbank Mem Fund Q Health Soc; 1984; 62(2):300-16. PubMed ID: 6425722 [TBL] [Abstract][Full Text] [Related]
46. Medicare program: Medicare Advantage and Prescription Drug Benefit programs: final marketing provisions. Final rule. Centers for Medicare & Medicaid Services (CMS), HHS Fed Regist; 2008 Sep; 73(182):54207-23. PubMed ID: 18985950 [TBL] [Abstract][Full Text] [Related]
48. State pharmaceutical assistance for the elderly and disabled: planning issues for program and nonprogram states. Hermanson S; Lago D; Smyer MA J Aging Soc Policy; 1991; 3(3):71-81. PubMed ID: 10186792 [TBL] [Abstract][Full Text] [Related]
49. Pharmacist's role in home i.v. therapy. McAllister JC Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S10-4. PubMed ID: 2505613 [TBL] [Abstract][Full Text] [Related]
51. Medicare prescription drugs: a benefit whose time has come. Benjamin GC Physician Exec; 1999; 25(4):89-90. PubMed ID: 10557496 [TBL] [Abstract][Full Text] [Related]
52. Comment on "Medicare financing reform: a new Medicare premium". Meyer JA Milbank Mem Fund Q Health Soc; 1984; 62(2):317-24. PubMed ID: 6371599 [TBL] [Abstract][Full Text] [Related]
53. Part "D" for "defective"--the Medicare drug-benefit chaos. Avorn J N Engl J Med; 2006 Mar; 354(13):1339-41. PubMed ID: 16571877 [No Abstract] [Full Text] [Related]
54. Alternative Medicare financing sources. Long SH; Smeeding TM Milbank Mem Fund Q Health Soc; 1984; 62(2):325-48. PubMed ID: 6371600 [TBL] [Abstract][Full Text] [Related]
55. The Medicare prescription drug proposals and health insurance risk. Gencarelli DM NHPF Issue Brief; 2003 Sep; (793):1-12. PubMed ID: 12964574 [TBL] [Abstract][Full Text] [Related]
56. The Medicare Catastrophic Coverage Act of 1988 effects hospital pharmacies. Wilson CN Hosp Pharm; 1988 Nov; 23(11):1029-34. PubMed ID: 10302982 [No Abstract] [Full Text] [Related]
57. Fraud and abuse find a home in managed care. Lawrence J Manag Care; 1997 Oct; 6(10):62, 65-8. PubMed ID: 10174554 [No Abstract] [Full Text] [Related]
58. Medicare and chronic conditions. Anderson GF N Engl J Med; 2005 Jul; 353(3):305-9. PubMed ID: 16034019 [No Abstract] [Full Text] [Related]
59. Actuarial status of the Social Security and Medicare programs. Soc Secur Bull; 1993; 56(1):52-9. PubMed ID: 8211564 [TBL] [Abstract][Full Text] [Related]
60. Actuarial status of the Hospital Insurance and Supplementary Medical Insurance Trust Funds. King RE Soc Secur Bull; 1983 Oct; 46(10):9-15. PubMed ID: 6359493 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]